Disease surveillance
Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances.
A key part of modern disease surveillance is the practice of disease case reporting.
History[edit]
Disease surveillance was first implemented in France in 1850 by Dr. Louis-René Villermé, who used it to study the correlation between economic status and cholera prevalence.
Types of Surveillance[edit]
There are several types of disease surveillance including passive surveillance, active surveillance, sentinel surveillance, and syndromic surveillance.
Passive Surveillance[edit]
In passive surveillance, laboratories and health care providers send reports to a health department on the basis of a set of rules and regulations. While it is low cost, it may underestimate the prevalence of a disease and there may be delays in the notification of health departments.
Active Surveillance[edit]
In active surveillance, the health department is proactive and contacts health care providers or laboratories requesting information about diseases.
Sentinel Surveillance[edit]
Sentinel surveillance is used when high-quality data are needed about a particular disease that cannot be obtained through passive surveillance.
Syndromic Surveillance[edit]
Syndromic surveillance is the analysis of medical data to detect or anticipate disease outbreaks. It is a relatively new type of surveillance that can be used to detect outbreaks of new diseases, as well as to monitor the rate of diseases already present in the population.
Benefits[edit]
Disease surveillance allows for the monitoring of disease trends over time and the identification of populations or regions at high risk. It also helps in the early detection of outbreaks and in the evaluation of control measures.
Challenges[edit]
Despite its benefits, disease surveillance faces several challenges including logistical difficulties, lack of resources, and issues related to data management and interpretation.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


